Inducible nitric oxide synthase expression is related to angiogenesis, bcl-2 and cell proliferation in hepatocellular carcinoma

Journal of Zhejiang University: Science

Volumn 4, Issue 2, 2003, Pages 221-227

  Peng, Jia Ping ^a   Zheng, Shu ^a   Xiao, Zuo Xiang ^a   Zhang, Su Zhan ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Angiogenesis; Bcl 2; Flow cytometric analyse; Hepatocellular carcinoma; Nitric oxide synthase

Indexed keywords

CELLS; OXIDES; TISSUE; TUMORS;

ANGIOGENESIS; FLOW CYTOMETRIC ANALYSE; HEPATOCELLULAR CARCINOMA; NITRIC OXIDE SYNTHASE;

MEDICAL PROBLEMS;

ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; NITRIC OXIDE SYNTHASE; PROTEIN BCL 2; PROTEIN P53; SIGNAL PEPTIDE; VASCULOTROPIN; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; CELL DIVISION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; STATISTICS; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; LIVER NEOPLASMS; LYMPHOKINES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE; PROTO-ONCOGENE PROTEINS C-BCL-2; STATISTICS; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0038485919     PISSN: 10093095     EISSN: None     Source Type: Journal    
DOI: 10.1631/jzus.2003.0221     Document Type: Article

References (18)

1. Ambs, S., Bennett, W. P., Merriam, W. G., Ogunfusika M.O, Oser, S.M., Khan, M. A., Jones, R.T. and Harris, C. C., 1998. Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53. Br J Cancer, 78(2): 233-9.
2. Del-Brutto, O.H., Dolezal, M., Castillo, P. R. and Garcia, H. H., 2000. Neurocysticercosis and oncogenesis. Archi. Med. Res., 31(2): 151-155.
3. Dodd, F., Limoges, M., Boudreau, R., Rowden, G., Murphy, P.R. and Too, C.K., 2000. L-arginine inhibits apoptosis via a NO-dependent mechanism in Nb2 lymphoma cells. J Cell Biochem, 77(4): 624-634.
4. Dulak, J., Jozkowicz, A., Denbinska, K.A., Guevara, I., Zdzienicka, A., Zmudzinska-Grochot, D., Florek, I., Wojtowicz, A., Szuba, A. and Cooke, J.P., 2000. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler Thromb Vasc. Biol, 20: 659-666.
5. Edwards, P., Cendan, J.C., Topping, D.B., Moldawer, L.L., MacKay, S., Copeland-EMIII and Lind, D.S., 1996. Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo. J Surg Res, 63 (1): 49-52
6. Folkman, J., 1990. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst, 82: 4-6.
7. Gallo, O., Masini, E., Morbidelli, L., Franchi, A., Fini-Storchi, I., Vergari, W. A. and Ziche, M., 1998. Role of nitric oxide in angogenesis and tumor progression head and neck cancer. J Natl Cancer Res, 58: 334-341.
8. Klotz, T., Bloch, W., Jacobs, G., Niggemann, S., Engelmann, U. and Addicks, K., 1999. Immunolocalization of inducible and constitutive nitric oxide synthases in human bladder cancer. Urology, 54: 416-419.
9. Lala, P.K. and Orucevic, A., 1998. Role of nitric oxide in tumor progression: Lessons from experimental tumors. Cancer Rev, 17: 91-106.
10. Murata, J.I., Tada, M., Iggo, R.D., Sawamura, Y., Shinohe, Y. and Abe, H., 1997. Nitric oxide as a carcinogen: analysis by yeast functional assay of inactivating p53 mutations induced by nitric oxide. Mutation Research, 379 (2): 211-218.
11. Pidgeon, G.P., Barr, M.P., Harmey, J.H., Foley, D. A. and Bouchier-Hayes, D. J., 2001. Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells. Br J Cancer, 85(2): 273-278.
12. Rahman, M. A., Dhar, D. K., Yamaguchi, E., Maruyama, S., Sato, T., Hayashi, H., Ono, T., Yamanoi, A., Kohno, H. and Nagasue, N., 2001. Coexpression of Inducible Nitric synthaseand COX-2 in Hepatocellular Carcinoma and Surrounding Liver: Possible Involvement of COX-2 in the Angiogenesis of Hepatitis C virus-positive Cases. Clin. Cancer Res., 7: 1325-1332.
13. Risau, W., 1997. Mechanisms of angiogenesis. Nature, 386: 353-364.
14. Shigeki H., Keisuke F. and Shigeto M., L., 2001. Vascular smooth muscle maintains the levels of Bcl-2 in endothelial cells. Atherosclerosis, 154(2): 309-316.
15. Swana, H. S., Smith, S. D., Perrota, P. L., Saito, N., Wheeler, M. A. and Weiss, R. M., 1999. Inducible nitric oxide synthase with transitional cell carcinoma of the bladder. J Urol, 161: 630-634.
16. Thompson, D.C., Porter, S.E., Bauer, A.K., Das, K. C., Ou, B. and Dwyer, NL., 1998. Cytokine-induced nitric Dxide formation in normal but not in neoplastic murine lung epithelial cell lines. Am J Physiol, 274(6): 922-932.
17. Ziche, M., Morbidelli, L., Masini, E., Amerini, S., Granger, H. J., Maggi, C. A., Geppetti, P. and Led-Ziche, M., 1994. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest, 94: 2036-2044.
18. Ziche, M., Morbidelli, L. and Choudhuri, R., 1997. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest, 99 (11): 2625-2634.